Clinical Trial Record

Return to Clinical Trials

The MONITOR Study: Remote Monitoring Of a Nutrition Intervention To Optimize Treatment Response


2023-09-12


2026-02-13


2026-06


40

Study Overview

The MONITOR Study: Remote Monitoring Of a Nutrition Intervention To Optimize Treatment Response

The purpose of the study is to evaluate the feasibility and acceptability of a remote nutrition coaching and monitoring intervention during the 12-weeks of active chemotherapy for borderline resectable and locally advanced pancreatic cancer participants.

N/A

  • Pancreatic Cancer
  • BEHAVIORAL: Quality fo Life Questionnaire (FHSI)
  • BEHAVIORAL: Vioscreen Food Frequency Questionnaire (FFQ)
  • BEHAVIORAL: Educational Handouts
  • BEHAVIORAL: NutritionCoaching
  • BEHAVIORAL: Follow-Up Survey
  • BEHAVIORAL: Functional Assessment of Anorexia/Cachexia Treatment (FAACT) Questionnaire
  • BEHAVIORAL: Patient Reported Outcomes Measure- Cognitive Function (PROMIS-Cog) Questionnaire
  • MCC-22523

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates Results Reporting Dates Study Record Updates

2023-09-11  

N/A  

2025-09-12  

2023-09-15  

N/A  

2025-09-15  

2023-09-22  

N/A  

2025-09  

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

Design Details

Primary Purpose:
Supportive Care


Allocation:
Randomized


Interventional Model:
Parallel


Masking:
None


Arms and Interventions

Participant Group/ArmIntervention/Treatment
EXPERIMENTAL: MONITOR group: Monitoring of a Nutrition Intervention to Optimize treatment Response

Participants randomized to the MONITOR arm will be provided dietary coaching biweekly to discuss nutrition concerns, anti-inflammatory diet compliance, and set SMART goals based on their most recent Vioscreen food frequency questionnaires.

BEHAVIORAL: Quality fo Life Questionnaire (FHSI)

  • Participants will take a survey at baseline and visit 2 (weeks 6-8), and visit 3 (week 10-14). The Functional Assessment of Cancer Therapy Hepatobiliary Cancer Symptom Index-8 (FHSI) questionnaire uses a 5-point Likert-type scale, 0=not at all and 4=Very

BEHAVIORAL: Vioscreen Food Frequency Questionnaire (FFQ)

  • Participants will receive a web-based link and information to complete VioScreen, a web-based food frequency questionnaire, which allows participants to choose the average frequency of consumption of food items over a given time frame (1 month, 3 month, 1

BEHAVIORAL: NutritionCoaching

  • Participants will receive bi-weekly nutrition coaching on anti-inflammatory dietary patterns and foods.

BEHAVIORAL: Follow-Up Survey

  • Participants will complete a custom exit/follow up survey regarding relevance, acceptability, intervention length and timing, an barriers/facilitators. This survey contains 38 questions scored from 1 -Strongly agree to 5-Strongly disagree. A lower score i

BEHAVIORAL: Functional Assessment of Anorexia/Cachexia Treatment (FAACT) Questionnaire

  • The FAACT questionnaire uses a 5 point Likert-type scale, 0=Not at all, 4=Very much. A higher score indicates better appetite and quality of life.

BEHAVIORAL: Patient Reported Outcomes Measure- Cognitive Function (PROMIS-Cog) Questionnaire

  • Participants will complete the PROMIS-Cog form which measures self-reported cognitive deficits. The questionnaire uses a 5 point Likert-type scale, 1=Very often and 5=Never. A higher score indicates higher cognitive function.
ACTIVE_COMPARATOR: Standard Usual Care

Standard Usual Care participants will receive usual nutrition care received in the Moffitt Cancer Center pancreatic clinic, in addition to handouts on diet.

BEHAVIORAL: Quality fo Life Questionnaire (FHSI)

  • Participants will take a survey at baseline and visit 2 (weeks 6-8), and visit 3 (week 10-14). The Functional Assessment of Cancer Therapy Hepatobiliary Cancer Symptom Index-8 (FHSI) questionnaire uses a 5-point Likert-type scale, 0=not at all and 4=Very

BEHAVIORAL: Educational Handouts

  • Participants will receive educational handouts on diet.

BEHAVIORAL: Follow-Up Survey

  • Participants will complete a custom exit/follow up survey regarding relevance, acceptability, intervention length and timing, an barriers/facilitators. This survey contains 38 questions scored from 1 -Strongly agree to 5-Strongly disagree. A lower score i

BEHAVIORAL: Functional Assessment of Anorexia/Cachexia Treatment (FAACT) Questionnaire

  • The FAACT questionnaire uses a 5 point Likert-type scale, 0=Not at all, 4=Very much. A higher score indicates better appetite and quality of life.

BEHAVIORAL: Patient Reported Outcomes Measure- Cognitive Function (PROMIS-Cog) Questionnaire

  • Participants will complete the PROMIS-Cog form which measures self-reported cognitive deficits. The questionnaire uses a 5 point Likert-type scale, 1=Very often and 5=Never. A higher score indicates higher cognitive function.
Primary Outcome MeasuresMeasure DescriptionTime Frame
Recruitment Rate -FeasibilityThe study will be deemed feasible if >/= 60% of eligible participants are enrolledUp to 8 months
Retention Rate - FeasibilityThe study will be deemed feasible if >/=70% of participants complete the post-intervention questionnaireat 12 weeks
Adherence - FeasibilityThe study will be deemed feasible if average attendance is >/=4 weeks of sessions (out of 6) for MONITOR armat 12 weeks
Secondary Outcome MeasuresMeasure DescriptionTime Frame
Participant Satisfaction with Overall Program- AcceptabilityThe study will be deemed acceptable based on the satisfaction score on follow-up survey. The follow-up survey uses open-ended and likert-style questions regarding 1) relevance and applicability of the MONITOR intervention content and objective/subjective data collection methods; 2) intervention length and timing; and 3) barriers/facilitators to participation and retention. On a 5-point Lkert-type scale, a(1) =strongly agree and e(5)=strongly disagree. Participant Satisfaction with Overall Program is determined by a score >/=3 on a 5-point scale.at 12 weeks
Participant intent to continue using skills- AcceptabilityThe study will be deemed acceptable based on the satisfaction score on follow-up survey. The follow-up survey uses open-ended and likert-style questions regarding 1) relevance and applicability of the MONITOR intervention content and objective/subjective data collection methods; 2) intervention length and timing; and 3) barriers/facilitators to participation and retention. On a 5-point Lkert-type scale, a(1) =strongly agree and e(5)=strongly disagree. Participant intent to continue using skills- is determined by a score >/=3 on a 5-point scale.at 12 weeks
Participant perception of utility of knowledge gained - AcceptabilityThe study will be deemed acceptable based on the satisfaction score on follow-up survey. The follow-up survey uses open-ended and likert-style questions regarding 1) relevance and applicability of the MONITOR intervention content and objective/subjective data collection methods; 2) intervention length and timing; and 3) barriers/facilitators to participation and retention. On a 5-point Lkert-type scale, a(1) =strongly agree and e(5)=strongly disagree. Participant perception of utility of knowledge gained is determined by a score >/=3 on a 5-point scale.at 12 weeks

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person’s general health condition or prior treatments.

Ages Eligible for Study:
ALL

Sexes Eligible for Study:
18 Years

Accepts Healthy Volunteers:

    Inclusion Criteria:

  • Men or women 18 years of age or more
  • Newly diagnosed, in place tumors of the pancreas
  • No documented or observable psychiatric or neurological disorders that would interfere with study participation (e.g., dementia, psychosis)
  • Able to speak and read English
  • Able to consume food orally
  • Chemotherapy naive
  • Scheduled to receive treatment with chemotherapy
  • Able to provide verbal informed consent

  • Exclusion Criteria:

  • Women who are pregnant
  • Pancreatic cancer not the primary diagnosis
  • Patients on enteral or parental nutrition
  • Patients with metastatic pancreatic cancer
  • Patients with evidence of impeding bowel obstruction
  • Patients presenting with ascites

Collaborators and Investigators

This is where you will find people and organizations involved with this study.


    • PRINCIPAL_INVESTIGATOR: Sylvia Crowder, PhD, Moffitt Cancer Center

    Publications

    The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

    General Publications

    No publications available